CARM
Carisma Therapeutics
CARM
CARM
Delisted
CARM was delisted on the 10th of October, 2025.
25 hedge funds and large institutions have $8.34M invested in Carisma Therapeutics in 2016 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
Holders
25
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$1.67M | |
| 2 | +$55K | |
| 3 | +$45K | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$25K |
| 5 |
Bank of New York Mellon
New York
|
+$13K |
Top Sellers
| 1 | -$387K | |
| 2 | -$53.8K | |
| 3 | -$47K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$16K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$6K |